Skip to main content

Government News

  • Niti Aayog has developed two bills to regulate and promote Indian medicine systems that include ayurveda, yoga and naturopathy and homeopathy.The bill of the National Commission for Indian Systems of Medicine (NCISM), 2017 will cover Ayurveda, Unani, Siddha and Sowa-Rigpa, yoga and naturopathy. The draft of the National Commission for Homeopathy Act of 2017 will also cover biochemical remedies.

  • A question from the Parliament " regarding the influence of vaccine-makers on the immunisation plan" raised the issue of funding the Indian Academy of Pediatrics (IPA), the body representing more than 23,000 pediatricians in India. A look at its finances shows how much depends on the IPA on the financing of the pharmaceutical industry, especially the vaccine manufacturers.

  • The draft National Strategic Plan for the Eradication of Tuberculosis (2017-2025), which will be implemented shortly, offers benefits that include Rs2,000 for patients visiting private sector physicians. The Center is considering incentives for private doctors treating TB patients, as well as financial benefits and free medicines for those visiting them as part of its "aggressive" strategy to eliminate the disease.

    [adsense:336x280:8701650588]

  • The government said it was working on measures to reduce India's dependence on large-scale imports of active pharmaceutical ingredients (APIs), as members of Rajya Sabha expressed concern about question. Responding to zero-hour concerns, Trade Minister Nirmala Sitharaman said the huge imports of pharmaceutical raw materials were a matter of serious concern.

  • A high-level committee recommended a new institutional framework for homeopathy and Ayurveda in India, continuing its efforts to rationalize the country's medical system. The Committee stated that the statutory bodies governing the education system have failed to attract qualified and qualified people based on merit due to lack of transparency.

  • Prices for all essential medicines are likely to increase by almost 2% from 1 April. The National Pharmaceutical Pricing Authority (NPPA) has asked companies to submit the documents required to benefit from the annual price increase based on the wholesale price index. Under the Drugs Price Control Order, the regulator revises prices of all essential medicines annually based on the changes in WPI.

Subscribe to Government News